Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $178.35 million. The enterprise value is $160.30 million.

Market Cap	178.35M
Enterprise Value	160.30M

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024, after market close.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

Nanobiotix has 47.40 million shares outstanding. The number of shares has increased by 23.04% in one year.

Current Share Class	n/a
Shares Outstanding	47.40M
Shares Change (YoY)	+23.04%
Shares Change (QoQ)	+21.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	21.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	3.54
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.42

Current Ratio	1.42
Quick Ratio	1.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.02%
Return on Capital (ROIC)	-101.38%
Revenue Per Employee	$443,335
Profits Per Employee	-$351,620
Employee Count	102
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, Nanobiotix has paid $279,653 in taxes.

Income Tax	279,653
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.47% in the last 52 weeks. The beta is 1.40, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-33.47%
50-Day Moving Average	4.70
200-Day Moving Average	5.62
Relative Strength Index (RSI)	43.48
Average Volume (20 Days)	8,769

Short Selling Information

Short Interest	33,765
Short Previous Month	30,634
Short % of Shares Out	0.07%
Short % of Float	0.16%
Short Ratio (days to cover)	5.50

Income Statement

In the last 12 months, Nanobiotix had revenue of $45.22 million and -$35.87 million in losses. Loss per share was -$0.84.

Revenue	45.22M
Gross Profit	45.22M
Operating Income	-23.99M
Pretax Income	-43.27M
Net Income	-35.87M
EBITDA	-23.89M
EBIT	-23.99M
Loss Per Share	-$0.84

Full Income Statement

Balance Sheet

The company has $71.08 million in cash and $52.68 million in debt, giving a net cash position of $18.39 million or $0.39 per share.

Cash & Cash Equivalents	71.08M
Total Debt	52.68M
Net Cash	18.39M
Net Cash Per Share	$0.39
Equity (Book Value)	-23.33M
Book Value Per Share	-0.49
Working Capital	25.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.11 million and capital expenditures -$529,305, giving a free cash flow of -$1.61 million.

Operating Cash Flow	-1.11M
Capital Expenditures	-529,305
Free Cash Flow	-1.61M
FCF Per Share	-$0.03

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -53.06% and -79.31%.

Gross Margin	100.00%
Operating Margin	-53.06%
Pretax Margin	-78.69%
Profit Margin	-79.31%
EBITDA Margin	-52.83%
EBIT Margin	-53.06%
FCF Margin	-34.82%

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.04%
Shareholder Yield	-23.04%
Earnings Yield	-20.11%
FCF Yield	-0.90%

Analyst Forecast

The average price target for Nanobiotix is $11.50, which is 203.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	203.03%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	10.11%
EPS Growth Forecast (5Y)	-12.40%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -3.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.97
Piotroski F-Score	4